BACKGROUND: The rapid spread of severe acute respiratory syndrome coronavirus-2 or SARS-CoV-2 necessitated a scaled treatment response to the novel coronavirus disease 2019 (COVID-19). OBJECTIVE: This study aimed to characterize the design and rapid implementation of a complex, multimodal, technology response to COVID-19 led by the Intermountain Healthcare's (Intermountain's) Care Transformation Information Systems (CTIS) organization to build pandemic surge capacity. METHODS: Intermountain has active community-spread cases of COVID-19 that are increasing. We used the Centers for Disease Control and Prevention Pandemic Intervals Framework (the Framework) to characterize CTIS leadership's multimodal technology response to COVID-19 at Intermountain. We provide results on implementation feasibility and sustainability of health information technology (HIT) interventions as of June 30, 2020, characterize lessons learned and identify persistent barriers to sustained deployment. RESULTS: We characterize the CTIS organization's multimodal technology response to COVID-19 in five relevant areas of the Framework enabling (1) incident management, (2) surveillance, (3) laboratory testing, (4) community mitigation, and (5) medical care and countermeasures. We are seeing increased use of traditionally slow-to-adopt technologies that create additional surge capacity while sustaining patient safety and care quality. CTIS leadership recognized early that a multimodal technology intervention could enable additional surge capacity for health care delivery systems with a broad geographic and service scope. A statewide central tracking system to coordinate capacity planning and management response is needed. Order interoperability between health care systems remains a barrier to an integrated response. CONCLUSION: The rate of future pandemics is estimated to increase. The pandemic response of health care systems, like Intermountain, offers a blueprint for the leadership role that HIT organizations can play in mainstream care delivery, enabling a nimbler, virtual health care delivery system that is more responsive to current and future needs. Thieme. All rights reserved.
BACKGROUND: The rapid spread of severe acute respiratory syndrome coronavirus-2 or SARS-CoV-2 necessitated a scaled treatment response to the novel coronavirus disease 2019 (COVID-19). OBJECTIVE: This study aimed to characterize the design and rapid implementation of a complex, multimodal, technology response to COVID-19 led by the Intermountain Healthcare's (Intermountain's) Care Transformation Information Systems (CTIS) organization to build pandemic surge capacity. METHODS: Intermountain has active community-spread cases of COVID-19 that are increasing. We used the Centers for Disease Control and Prevention Pandemic Intervals Framework (the Framework) to characterize CTIS leadership's multimodal technology response to COVID-19 at Intermountain. We provide results on implementation feasibility and sustainability of health information technology (HIT) interventions as of June 30, 2020, characterize lessons learned and identify persistent barriers to sustained deployment. RESULTS: We characterize the CTIS organization's multimodal technology response to COVID-19 in five relevant areas of the Framework enabling (1) incident management, (2) surveillance, (3) laboratory testing, (4) community mitigation, and (5) medical care and countermeasures. We are seeing increased use of traditionally slow-to-adopt technologies that create additional surge capacity while sustaining patient safety and care quality. CTIS leadership recognized early that a multimodal technology intervention could enable additional surge capacity for health care delivery systems with a broad geographic and service scope. A statewide central tracking system to coordinate capacity planning and management response is needed. Order interoperability between health care systems remains a barrier to an integrated response. CONCLUSION: The rate of future pandemics is estimated to increase. The pandemic response of health care systems, like Intermountain, offers a blueprint for the leadership role that HIT organizations can play in mainstream care delivery, enabling a nimbler, virtual health care delivery system that is more responsive to current and future needs. Thieme. All rights reserved.
Authors: Ateev Mehrotra; Anupam B Jena; Alisa B Busch; Jeffrey Souza; Lori Uscher-Pines; Bruce E Landon Journal: JAMA Date: 2016-05-10 Impact factor: 56.272
Authors: Curtis H Weiss; Jakob I McSparron; Rohini S Chatterjee; Derrick Herman; Eddy Fan; Kevin C Wilson; Carey C Thomson Journal: Ann Am Thorac Soc Date: 2017-08
Authors: Eddy Fan; Lorenzo Del Sorbo; Ewan C Goligher; Carol L Hodgson; Laveena Munshi; Allan J Walkey; Neill K J Adhikari; Marcelo B P Amato; Richard Branson; Roy G Brower; Niall D Ferguson; Ognjen Gajic; Luciano Gattinoni; Dean Hess; Jordi Mancebo; Maureen O Meade; Daniel F McAuley; Antonio Pesenti; V Marco Ranieri; Gordon D Rubenfeld; Eileen Rubin; Maureen Seckel; Arthur S Slutsky; Daniel Talmor; B Taylor Thompson; Hannah Wunsch; Elizabeth Uleryk; Jan Brozek; Laurent J Brochard Journal: Am J Respir Crit Care Med Date: 2017-05-01 Impact factor: 21.405
Authors: Samuel M Brown; Ithan D Peltan; Brandon Webb; Naresh Kumar; Nathan Starr; Colin Grissom; Whitney R Buckel; Raj Srivastava; Estelle S Harris; Lindsay M Leither; Stacy A Johnson; Robert Paine; Tom Greene Journal: Ann Am Thorac Soc Date: 2020-08
Authors: Vivian Hsiao; Thevaa Chandereng; Robin L Lankton; Jeffrey A Huebner; Jeffrey J Baltus; Grace E Flood; Shannon M Dean; Amye J Tevaarwerk; David F Schneider Journal: Appl Clin Inform Date: 2021-06-09 Impact factor: 2.762
Authors: Dev Dash; Arjun Gokhale; Birju S Patel; Alison Callahan; Jose Posada; Gomathi Krishnan; William Collins; Ron Li; Kevin Schulman; Lily Ren; Nigam H Shah Journal: Appl Clin Inform Date: 2022-03-02 Impact factor: 2.342
Authors: Katherine J Holzer; Sunny S Lou; Charles W Goss; Jaime Strickland; Bradley A Evanoff; Jennifer G Duncan; Thomas Kannampallil Journal: Appl Clin Inform Date: 2021-06-02 Impact factor: 2.762